Ahmet Davut Aksu: Plasminogen Supplementation Enhances Alteplase Efficacy in Systemic Embolization Model
Ahmet Davut Aksu, Researcher at University of Masarykova, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
“Excited to share this milestone: our plasminogen paper is finally published!
I’m thrilled to share that our work has been published in the Journal of Thrombosis and Thrombolysis by Springer Nature!
This publication represents the core of my PhD thesis and marks a major milestone in my PhD journey, alongside my work on isolated heart research.
In this study, we demonstrate how plasminogen supplementation enhances alteplase efficacy and improves fibrinolysis rates, using our validated systemic embolization rat model.
This has been a long and rewarding journey, and I’m grateful to everyone who supported me along the way.
Excited to keep building on these findings!”
Title: Plasminogen supplementation enhances alteplase fibrinolysis efficacy in a systemic embolization rat model
Authors: Ahmet Davut Aksu, Eliška Brhelová, Jana Hložková, Jana Doležalová, Radka Opatřilová, Robert Mikulík, Peter Scheer
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination
-
Oct 23, 2026, 15:29José Antonio García Erce: Preoperative Anemia Emerges as a Modifiable Surgical Risk in New POWER Study
-
Oct 23, 2026, 15:13Reza Shojaei: Manufactured Red Blood Cells vs Blood Donation
-
Oct 23, 2026, 14:29Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE
-
Oct 23, 2026, 13:56Chokri Ben Lamine: The Evolving Treatment Landscape of Persistent and Chronic ITP